Dorzolamide loaded niosomal vesicles: Comparison of passive and remote loading methods

Iranian Journal of Pharmaceutical Research

Volumn 16, Issue 2, 2017, Pages 413-422

  Dehaghi, Mohadeseh Hashemi ^a,b   Haeri, Azadeh ^a   Keshvari, Hamid ^c   Abbasian, Zahra ^a   Dadashzadeh, Simin ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF TEHRAN   (Iran)

^c AMIRKABIR UNIVERSITY OF TECHNOLOGY   (Iran)

Author keywords

Dorzolamide; Glaucoma; Niosome; Phosphate gradient method; Thin film hydration method

Indexed keywords

CHOLESTEROL; DORZOLAMIDE; LIPID; NIOSOME;

ARTICLE; DIFFUSION; DRUG ANALYSIS; DRUG BIOAVAILABILITY; DRUG CONCENTRATION; DRUG FORMULATION; DRUG RELEASE; DRUG SYNTHESIS; ENCAPSULATION; FILM; FREEZE THAWING; GLAUCOMA; LIGHT SCATTERING; SCANNING ELECTRON MICROSCOPY;

EID: 85021314942     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Bae HW, Lee KH, Lee N, Hong S, Seong GJ and Kim CY. Visual fields and OCT role in diagnosis of glaucoma. Optom. Vis. Sci. (2014) 91: 1312-9.
2. Donegan RK and Lieberman RL. Discovery of molecular therapeutics for glaucoma: Challenges, successes, and promising directions. J. Med. Chem. (2016) 59: 788-809.
3. Francis BA, Singh K, Lin SC, Hodapp E, Jampel HD, Samples JR and Smith SD. Novel glaucoma procedures: a report by the American Academy of Ophthalmology. Ophthalmology (2011) 118: 1466-80.
4. Toris CB. Pharmacotherapies for glaucoma. Curr. Mol. Med. (2010) 10: 824-40.
5. Gaudana R, Jwala J, Boddu SH and Mitra AK. Recent perspectives in ocular drug delivery. Pharm. Res. (2009) 26: 1197-216.
6. Lavik E, Kuehn MH and Kwon YH. Novel drug delivery systems for glaucoma. Eye (Lond). (2011) 25: 578-86.
7. Knight OJ and Lawrence SD. Sustained drug delivery in glaucoma. Curr. Opin. Ophthalmol. (2014) 25: 112-7.
8. Hathout RM, Mansour S, Mortada ND and Guinedi AS. Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies. AAPS PharmSciTech. (2007) 8: 1.
9. Kouchak M, Bahmandar R, Bavarsad N and Farrahi F. Ocular dorzolamide nanoliposomes for prolonged IOP reduction: in-vitro and in-vivo evaluation in rabbits. Iran. J. Pharm. Res. (2016) 15: 205-12.
10. Aggarwal D, Pal D, Mitra AK and Kaur IP. Study of the extent of ocular absorption of acetazolamide from a developed niosomal formulation, by microdialysis sampling of aqueous humor. Int. J. Pharm. (2007) 338: 21-6.
11. Warsi MH, Anwar M, Garg V, Jain GK, Talegaonkar S, Ahmad FJ and Khar RK. Dorzolamide-loaded PLGA/ vitamin E TPGS nanoparticles for glaucoma therapy: Pharmacoscintigraphy study and evaluation of extended ocular hypotensive effect in rabbits. Colloids Surf. B Biointerfaces (2014) 122: 423-31.
12. Zeng W, Li Q, Wan T, Liu C, Pan W, Wu Z, Zhang G, Pan J, Qin M, Lin Y, Wu C and Xu Y. Hyaluronic acid-coated niosomes facilitate tacrolimus ocular delivery: Mucoadhesion, precorneal retention, aqueous humor pharmacokinetics, and transcorneal permeability. Colloids Surf. B Biointerfaces (2016) 141: 28-35.
13. Abdelkader H, Ismail S, Hussein A, Wu Z, Al-Kassas R and Alany RG. Conjunctival and corneal tolerability assessment of ocular naltrexone niosomes and their ingredients on the henʹs egg chorioallantoic membrane and excised bovine cornea models. Int. J. Pharm. (2012) 432: 1-10.
14. ElMeshad AN and Mohsen AM. Enhanced corneal permeation and antimycotic activity of itraconazole against Candida albicans via a novel nanosystem vesicle. Drug Deliv. (2015) 1-9.
15. Abdelkader H, Alani AW and Alany RG. Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly, fabrication, characterization, drug delivery applications and limitations. Drug Deliv. (2014) 21: 87-100.
16. Honda M, Asai T, Oku N, Araki Y, Tanaka M and Ebihara N. Liposomes and nanotechnology in drug development: focus on ocular targets. Int. J. Nanomedicine (2013) 8: 495-503.
17. Marianecci C, Di Marzio L, Rinaldi F, Celia C, Paolino D, Alhaique F, Esposito S and Carafa M. Niosomes from 80s to present: the state of the art. Adv. Colloid Interface Sci. (2014) 205: 187-206.
18. Rajera R, Nagpal K, Singh SK and Mishra DN. Niosomes: a controlled and novel drug delivery system. Biol. Pharm. Bull. (2011) 34: 945-53.
19. Shukr MH. Novel in situ gelling ocular inserts for voriconazole-loaded niosomes: design, in vitro characterisation and in vivo evaluation of the ocular irritation and drug pharmacokinetics. J. Microencapsul. (2016) 33: 71-9.
20. Gaafar PM, Abdallah OY, Farid RM and Abdelkader H. Preparation, characterization and evaluation of novel elastic nano-sized niosomes (ethoniosomes) for ocular delivery of prednisolone. J. Liposome Res. (2014) 24: 204-15.
21. Loftsson T, Jansook P and Stefansson E. Topical drug delivery to the eye: dorzolamide. Acta Ophthalmol. (2012) 90: 603-8.
22. Ponticello GS, Sugrue MF, Plazonnet B and Durand-Cavagna G. Dorzolamide, a 40-year wait. From an oral to a topical carbonic anhydrase inhibitor for the treatment of glaucoma. Pharm. Biotechnol. (1998) 11: 555-74.
23. Fritze A, Hens F, Kimpfler A, Schubert R and Peschka-Suss R. Remote loading of doxorubicin into liposomes driven by a transmembrane phosphate gradient. Biochim. Biophys Acta. (2006) 1758: 1633-40.
24. Arzani G, Haeri A, Daeihamed M, Bakhtiari-Kaboutaraki H and Dadashzadeh S. Niosomal carriers enhance oral bioavailability of carvedilol: effects of bile salt-enriched vesicles and carrier surface charge. Int. J. Nanomedicine. (2015) 10: 4797-813.
25. Baillie AJ, Florence AT, Hume LR, Muirhead GT and Rogerson A. The preparation and properties of niosomes--non-ionic surfactant vesicles. J. Pharm. Pharmacol. (1985) 37: 863-8.
26. Sohrabi S, Haeri A, Mahboubi A, Mortazavi A and Dadashzadeh S. Chitosan gel-embedded moxifloxacin niosomes: An efficient antimicrobial hybrid system for burn infection. Int. J. Biol. Macromol. (2016) 85: 625-33.
27. Bajelan E, Haeri A, Vali AM, Ostad SN and Dadashzadeh S. Co-delivery of doxorubicin and PSC 833 (Valspodar) by stealth nanoliposomes for efficient overcoming of multidrug resistance. J. Pharm. Pharm. Sci. (2012) 15: 568-82.
28. Haeri A, Alinaghian B, Daeihamed M and Dadashzadeh S. Preparation and characterization of stable nanoliposomal formulation of fluoxetine as a potential adjuvant therapy for drug-resistant tumors. Iran. J. Pharm. Res. (2014) 13: 3-14.
29. Haeri A, Sadeghian S, Rabbani S, Anvari MS, Boroumand MA and Dadashzadeh S. Use of remote film loading methodology to entrap sirolimus into liposomes: preparation, characterization and in vivo efficacy for treatment of restenosis. Int. J. Pharm. (2011) 414: 16-27.
30. Haeri A, Sadeghian S, Rabbani S, Anvari MS, Erfan M and Dadashzadeh S. PEGylated estradiol benzoate liposomes as a potential local vascular delivery system for treatment of restenosis. J. Microencapsul. (2012) 29: 83-94.
31. Lewrick F and Suss R. Remote loading of anthracyclines into liposomes. Methods Mol. Biol. (2010) 605: 139-45.
32. Grit M and Crommelin DJ. Chemical stability of liposomes: implications for their physical stability. Chem. Phys. Lipids. (1993) 64: 3-18.
33. Hui SW and He NB. Molecular organization in cholesterol-lecithin bilayers by X-ray and electron diffraction measurements. Biochemistry (1983) 22: 1159-64.
34. El-Samaligy MS, Afifi NN and Mahmoud EA. Evaluation of hybrid liposomes-encapsulated silymarin regarding physical stability and in vivo performance. Int. J. Pharm. (2006) 319: 121-9.
35. Mokhtar M, Sammour OA, Hammad MA and Megrab NA. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Int. J. Pharm. (2008) 361: 104-11.
36. Zhao YZ and Lu CT. Increasing the entrapment of protein-loaded liposomes with a modified freeze-thaw technique: a preliminary experimental study. Drug Dev. Ind. Pharm. (2009) 35: 165-71.
37. Buchanan KD, Huang SL, Kim H, McPherson DD and MacDonald RC. Encapsulation of NF-kappaB decoy oligonucleotides within echogenic liposomes and ultrasound-triggered release. J. Control Release (2010) 141: 193-8.
38. Guo Y, Luo J, Tan S, Otieno BO and Zhang Z. The applications of Vitamin E TPGS in drug delivery. Eur. J. Pharm. Sci. (2013) 49: 175-86.
39. Maiti S, Paul S, Mondol R, Ray S and Sa B. Nanovesicular formulation of brimonidine tartrate for the management of glaucoma: in vitro and in vivo evaluation. AAPS PharmSciTech. (2011) 12: 755-63.
40. Guinedi AS, Mortada ND, Mansour S and Hathout RM. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. Int. J. Pharm. (2005) 306: 71-82.
41. Lakshmi P and Bhaskaran S. Phase II study of topical niosomal urea gel-an adjuvant in the treatment of psoriasis. Int. J. Pharm. Sci. Rev. Res. (2011) 7: 1-7.